Involvement of nitric oxide in nickel-induced hyperglycemia in rats

Nitric Oxide - Biology and Chemistry

Volumn 4, Issue 2, 2000, Pages 129-138

  Gupta, Sanjay ^a   Ahmad, Nihal ^a   Husain, Mirza M ^a   Srivastava, Ramesh C ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Cyclic GMP; Hyperglycemia; NG monomethyl L arginine; Nickel; Nitric oxide

Indexed keywords

CYCLIC GMP; N(G) METHYLARGININE; NICKEL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; ENZYME INHIBITION; EXPERIMENTAL MODEL; HYPERGLYCEMIA; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0034030952     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1006/niox.2000.0278     Document Type: Article

References (39)

1. Wink A. D., Vodovotz Y., Laval J., Dewhirst M. W., Mitchell J. B. The multifaceted roles of nitric oxide in cancer. Carcinogenesis. 19:1998;711-721.
2. Nathan C., Xie Q. W. Nitric oxide synthases: Roles, tolls, and controls. Cell. 78:1994;915-918.
3. Ignarro L. J. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30:1990;535-560.
4. Moncada S., Palmer R. M. J., Higgs E. A. Biosynthesis of nitric oxide from l-arginine. A pathway for the regulation of cell function and communication. Biochem. Pharmacol. 38:1989;1709-1715.
5. Ignarro L. J. Signal transduction mechanisms involving nitric oxide. Biochem. Pharmacol. 41:1991;485-490.
6. Ahmad N., Srivastava R. C., Agarwal R., Mukhtar H. Nitric oxide synthase and skin tumor promotion. Biochem. Biophys. Res. Commun. 232:1997;328-331.
7. Zerani M., Gobbetti A. NO sexual behaviour in newts. Nature. 382:1996;31.
8. Cosentino F., Luscher T. F. Endothelial dysfunction in diabetes mellitus. J. Cardiovasc. Pharmacol. 32:1998;54-61.
9. Piper G. M. Review of alterations in endothelial nitric oxide production in diabetes: Protective role of arginine on endothelial dysfunction. Hypertension. 5:1998;1047-1060.
10. Sobrevia L., Mann G. E. Dysfunction of the endothelial nitric oxide signaling pathway in diabetes and hyperglycemia. Exp. Physiol. 82:1997;423-452.
11. Honing M. L., Morrison P. J., Banga J. D., Stroes E. S., Rabelink T. J. Nitric oxide availability in diabetes mellitus. Diabetes Metab. Rev. 14:1998;241-249.
12. Schmidt H. H. H. W., Warner T. D., Ishii K., Sheng H., Murad F. Insulin secretion from pancreatic β cells caused by l-arginine-derived nitrogen oxides. Science. 256:1992;721-723.
13. Lukic M. L., Stosic-Grujicic S., Ostojic N., Chan W. L., Liew F. Y. Inhibition of nitric oxide generation affects the induction of diabetes by streptozotocin in mice. Biochem. Biophys. Res. Commun. 178:1991;913-920.
14. Tian L., Lawrence D. A. Metal-induced modulation of nitric oxide production in vitro by murine macrophages: Lead, nickel, and cobalt utilize different mechanisms. Toxicol. Appl. Pharmacol. 141:1996;540-547.
15. Horak E., Sunderman F. W. Jr. Effects of Ni(II) upon plasma glucogon and glucose in rats. Toxicol. Appl. Pharmacol. 33:1975;388-391.
16. Cartana J., Arola L. Nickel-induced hyperglycemia: The role of insulin and glucagon. Toxicology. 71:1992;181-192.
17. Alvarez C., Blade C., Cartana J. Alpha 2-adrenergic blockade prevents hyperglycemia and hepatic glutathione depletion in nickel-injected rats. Toxicol. Appl. Pharmacol. 121:1993;112-117.
18. Jun T., Wennmalm A. NO-dependent and -independent elevation of plasma levels of insulin and glucose in rats by l-arginine. Br. J. Pharmacol. 113:1994;345-348.
19. 2+-independent nitric oxide synthases. FEBS Lett. 291:1991;145-149.
20. Deliconstantinos G., Villiotou V., Stavrides J. C. Alterations of nitric oxide synthase and xanthine oxidase activities of human keratinocytes by ultraviolet B radiation. Biochem. Pharmacol. 51:1996;1727-1738.
21. DeFronzo R. A., Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 14:1991;173-194.
22. Horak E., Sunderman W. Effects of Ni(II), other divalent metal ions, and glucagon upon plasma glucose concentrations in normal, adrenalectomized and hypophysectomized rats. Toxicol. Appl. Pharmacol. 32:1975;316-329.
23. Clary J. J. Nickel chloride-induced metabolic changes in the rat and guinea pig. Toxicol. Appl. Pharmacol. 31:1975;55-65.
24. Dormer R. L., Kerbey A. L., McPherson M., Manley S., Ashcroft S. J. H., Schofield J. G., Randle P. J. The effect of nickel on secretory systems. Studies on the release of amylase, insulin and growth hormone. Biochem. J. 140:1973;135-142.
25. Torres J. T., Ribas B., Gracia M. C., Labato N. Effect of the nickel on the endocrine pancreas secretion of rat. Anke M., Schneider H. J., Bruckner C. Nickel, Spuren-element-Symposium. 1980;101-106 Abteilung Wissenschaftliche, Jena.
26. Flatt P. R., Barnett C. R., Swanston-Flatt S. K. Mechanism of pancreatic B-cell dysfunction and glucose toxicity in non-insulin-dependent diabetes. Biochem. Soc. Trans. 22:1994;18-23.
27. Kwon N. S., Lee S. H., Choi C. S., Kho T., Lee H. S. Nitric oxide generation from streptozotocin. FASEB J. 8:1994;529-533.
28. Fonovich de Schroeder T. M., Carattino M. D., Frontera M., Catanzaro O. L. Constitutive nitric oxide synthase (c-NOS) activity in Langerhans islets from streptozotocin diabetic rats. Braz. J. Med. Biol. Res. 31:1998;625-632.
29. Holstad M., Jansson L., Sandler S. Inhibition of nitric oxide formation by aminoguanidine: An attempt to prevent insulin-dependent diabetes mellitus. Gen. Pharmacol. 29:1997;697-700.
30. Sugimoto Y., Yamada J., Yoshikawa T., Horisaka K. Inhibitory effects of a nitric oxide synthase inhibitor, N(G)-nitro-d-glucose-induced hyperglycemia in rats. Biol. Pharm. Bull. 20:1997;1307-1309.
31. Berridge M. J. Inositol triphosphate and diacylglycerol: Two interacting second messengers. Annu. Rev. Biochem. 56:1987;159-193.
32. Smith J. B., Dwyer S. D., Smith L. Cadmium evokes inositol polyphosphate formation and calcium mobilization. J. Biol. Chem. 264:1988;7115-7118.
33. Rosen L. B., Ginty D. D., Greenberg M. E. Calcium regulation of gene expression. Adv. Second Messenger Phosphoprotein Res. 30:1995;225-253.
34. Massry S. G., Smogorzewski M. Role of elevated cytosolic calcium in the pathogenesis of complications in diabetes mellitus. Miner. Electrolyte Metab. 23:1997;253-260.
35. Panagiotidis G., Alm P., Lundquist I. Inhibition of islets nitric oxide synthase increases arginine-induced insulin release. Eur. J. Pharmacol. 229:1992;277-278.
36. Laychock S. G., Modica M. E., Cavanaugh C. T. l-Arginine stimulates cyclic guanosine 3′,5′-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: Evidence for l-arginine: Nitric oxide synthase. Endocrinology. 129:1991;3043-3052.
37. Green I. C., Delaney C. A., Cunningham J. M., Karmiris V., Southern C. Interleukin-1 beta effects on cyclic GMP and cyclic AMP in cultured rat islets of Langerhans - Arginine-dependence and relationship to insulin secretion. Diabetologia. 36:1993;9-16.
38. Pilkis S. J., El Magrabi M. R., Claus T. H. Hormonal regulation of hepatic gluconeogenesis and glycolysis. Annu. Rev. Biochem. 57:1988;755-783.
39. Gomez-Foix A. M., Rodriguez-Gil C., Fillat C., Guinovart J. J., Bosch F. Vanadate raises fructose-2,6-biphosphate concentrations and activates glycolysis in rat hepatocytes. Biochem. J. 255:1988;507-512.